It was found that, when compared with placebo treatment, vildagliptin increased by approximately 20% the insulin secretory response to intravenous glucose, and the slope relating insulin secretion to glucose; the maximal insulin secretory response to high glucose and intravenous arginine showed a clear trend to being stimulated as well 50 .
1
—
—